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Summary. Tumor necrosis factor a (TNFa) has been 
shown to trigger many signaling pathways. Following 
oligomerization by TNFa, the receptors TNF-RI and 
TNF-RI1 associate with adapter molecules via specific 
protein-protein interactions. The subsequent recruitment 
of downstream molecules to the receptor complex 
enables propagation of the TNFa signal. l k o  cellular 
responses to TNFa have been well documented, the 
induction of cell death and the activation of gene 
transcription for cell survival. TNFa-induced apoptosis 
involves the activation of caspase cascades, which 
culminate in the cleavage of specific cellular substrates 
to effect cell death. TNFa has also been implicated in 
various caspase-independent cell death processes. Two 
transcription factors activated by TNFa are nuclear 
factor KB (NFKB) and activating protein 1 (AP-1). 
Pathways that promote the activation of these 
transcription factors involve signaling molecules such as 
kinases, phospholipases, and sphingomyelinases. In 
addition to increased survival (anti-apoptotic) gene 
expression, NFKB and AP-1 also induce the expression 
of genes involved in inflammation, cell growth, and 
signal regulation. The past decade has witnessed the 
identification of numerous signaling intermediates 
implicated in TNFa  cellular responses. This article 
reviews the molecular mechanisms of TNFa signal 
transduction. In particular, pathways involved in cell 
death and transcription factor activation are discussed. 
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Abbreviations 
AIF: apoptosis inducing factor; AP-1: activating protein 
1; ASKI: apoptosis signal-regulating kinase 1; ASMase: 
acidic sphingomyelinase; CARD: caspase activating 
recruitment domain; CARDIAK: CARD containing 
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ICE-associated kinase; c-IAP: cellular inhibitor of 
apoptosis; CLAP: CARD-like apoptotic protein; CRD: 
cysteine-rich domain; DED: death effector domain; 
ERK: extracellular signal regulated kinase; FADD: Fas 
associated death domain; FAN: factor associated with 
NSMase; GCK(R): germinal center kinase (related); 
ICE: interleukin-113 convert ing enzyme; IRAK: 
interleukin-l receptor-associated kinase; JNK: c Jun  N- 
terminal kinase; MAPK: mitogen activated protein 
kinase; NIK: NFKB-inducing kinase; NFKB: nuclear 
factor KB; NSD: NSMase domain; NSMase: neutral 
sphingomyelinase; RAIDD: RIP-associated ICH-1 
homologous death domain; RIP: receptor interacting 
protein; SODD: silencer of death domains; TACE: 
TNFa  converting enzyme; TANK: TRAF-associated 
NFKB activator; TNFa:  tumor necrosis factor alpha; 
TNF-R: TNF receptor; TRADD: T N F  receptor 
associated death domain; TRAF: TNF receptor 
associated factor 
Introduction 
The effects of tumor necrosis factor a (TNFa) have 
been implicated in numerous physiological and 
pathological conditions. Until recently, knowledge 
concerning the global effects of TNFa far outweighed 
that of its cellular effects. Over the last few years, key 
players involved in mediating the cellular effects of 
TNFa have been identified. We now know that TNFa 
activates cell death pathways as well as transcription 
factors that signal survival pathways. This review will 
focus on the TNFa signaling pathways that enable cell 
death and transcription factor activation to occur. 
The role of tumor necrosis factor a in health and 
disease 
In 1893, a New York surgeon by the name of W.B. 
Coley was the first to document the effects of TNFa 
(Orlinick and Chao, 1998), although TNFa itself had not 
yet been identified. In 1975, an endotoxin-induced factor 
isolated from macrophages was discovered (Carswell et 






















